Uni of Liege backs €1m chitosan cartilage project

Uni of Liege backs €1m chitosan cartilage project

Related tags Bone

Chitosan supplier KitoZyme has joined with the University of Liege on a €1m seed project to launch a joint health product.

The project, Synolyne, will engage in a full spectrum of activity, from research and development to marketing of a product that will seek EU medical devices authorisation for arthrosis treatment via  cartilage repair.

The EU medical devices route is one that is familiar to KitoZyme, as it is making weight loss claims for its KiOnutrime-Cs fat-binding chitosan form under that legislation.

Synolyne will work with a gel containing KiOmedine-CsU, a highly purified form of the fungi-sourced nutrient.

Frost & Sullivan estimates that the market for products treating problems like arthrosis – which effects over half of over-65s and is the most serious problem after heart disease in that age group – is worth about $400m (€307m) in the US alone.

Such a product could offer alternatives to joint health staples like paracetamol and glucosamine.

KitoZyme, which has a partnership with Missouri-based Stratum Nutrition on certain nutrients, said in a statement: “KitoZyme received shares in the new company in exchange for its contribution in kind (an intellectual property licence agreement). The company will also receive royalties on future sales of Synolyne and will supply the biomaterial involved in the composition of the medical device, KiOmedine-CsU.”

University participation will include Professor Henrotin, director of the UROC (Bone and Cartilage Research Unit).

Related news

Show more

Related products

show more

Nextida: Precision where it matters

Nextida: Precision where it matters

Content provided by Rousselot | 09-May-2024 | Product Brochure

NEXTIDA™ is an innovative platform of specific collagen peptide compositions with new targeted health benefits. Built and backed by science, Nextida stands...

Women's Health Before, During & Beyond Menopause

Women's Health Before, During & Beyond Menopause

Content provided by Akay Bioactives | 26-Apr-2024 | White Paper

Discover the science of FenuSmart®, a unique fenugreek seed extract that merges ancient wisdom with modern clinical research to support women's health...

Related suppliers

Follow us


View more